88IV - PR Newswire Asia's news


Ascletis Announces Fixed-Dose Combination of ASC30, Once-Daily Oral Small Molecule GLP-1R Agonist, and ASC39, Once-Daily Oral Small Molecule Amylin-Selective Amylin Receptor Agonist, for Clinical Development -Fixed - dose combination of ASC30 and ASC39 (ASC30_39 FDC) tablets, dosed orally in dogs, demonstrated comparable pharmacokinetics to those observed in their respective monotherapies in a head-to-head ... 2026-04-07T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Akeso Presents Updated Data on Cadonilimab Combination Therapy in PD-(L)1 Inhibitor-Resistant Advanced NSCLC at ELCC 2026 HONG KONG , April 7, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that, at the 2026 European Lung Cancer Congress (ELCC 2026), it reported updated ... 2026-04-07T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
CGBIO Showcases Comprehensive Medical Device Portfolio at KIMES 2026 Achieves KRW 5.3 Billion in Contract Results - Presented key product lines spanning aesthetic, wound care, bone and spine, and surgical fields - Signed supply agreements totaling KRW 5.3 billion with partners from Singapore, Malaysia, Pakistan, ... 2026-04-07T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement MELBOURNE, Australia and INDIANAPOLIS , April 7, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") provides a market update on its commercial and operational ... 2026-04-07T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
NYSE Content Update: Join Us and 6,500+ Attendees at Marquee AI Event HumanX NYSE issues a pre-market daily advisory direct from the trading floor. ... 2026-04-06T Banking/Financial Service Biotechnology Computer/Electronics
Alar Breaks Key Barriers in Ketamine Therapy with Positive Phase 1 Results for Long-Acting Injectable ALA-3000 for Treatment-Resistant Depression By reducing dissociation and sedation risk, ALA-3000 may eliminate the ≥2-hour post-dose monitoring requirement, reducing clinic operating costs, improving patient throughput, and supporting a more cost-effective ... 2026-04-06T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
GC Biopharma Enhances IVIG Safety Profile with Advanced Prothrombotic Impurity Detection Technology Proprietary analytical method for precise Factor XI (FXI) measurement published in the Journal of Microbiology and Biotechnology Novel IgG Blocker eliminates heterophilic antibody interference, ensuring ... 2026-04-06T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Fast-Acting Covalent Protein Drugs From a New High-Throughput Platform HANGZHOU, China , April 3, 2026 /PRNewswire/ -- A team led by principal investigators Bobo Dang and Ting Zhou at Westlake University/Westlake Laboratory reported in Science a high-throughput platform ... 2026-04-03T Biotechnology Education Health Care/Hospital Publishing/Information Service
Assembling Over 1,000 Human Genomes Affordably: New Method Powers Medicine's Future HANGZHOU, China , April 3, 2026 /PRNewswire/ -- A research team led by Zhen-Xing Endowed Professor Jian Yang at the School of Life Sciences, Westlake University, together with collaborators, ... 2026-04-03T Biotechnology Health Care/Hospital Higher Education Medical/Pharmaceuticals
Syneron Bio Announces Completion of $150 Million Series B Financing BEIJING , April 3, 2026 /PRNewswire/ -- Syneron Bio, a leader in intelligent platform-driven macrocyclic peptide drug discovery, announced the successful closing of its Series B financing on March 31th. ... 2026-04-03T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology